Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 163,643 |
|
|||||
| News | - | ||||||
| Day High | 400.38 | Low High |
|||||
| Day Low | 393.00 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vertex Pharmaceuticals Inc | VRTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -6.81 | -1.70% | 393.95 | 10:52:06 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 399.42 | 393.00 | 400.38 | 400.76 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,817 | 163,643 | $ 396.23 | $ 64,839,623 | - | 316.43 - 448.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:52:05 | 12 | $ 393.90 | USD |
Vertex Pharmaceuticals (VRTX) Options Flow Summary
Vertex Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 103.52B | 258.31M | - | 9.92B | 3.57B | 13.82 | 28.99 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Vertex Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 394.19 | 406.86 | 391.01 | 398.54 | 1,112,225 | -0.24 | -0.06% |
| 1 Month | 419.48 | 421.45 | 391.01 | 402.03 | 972,988 | -25.53 | -6.09% |
| 3 Months | 434.00 | 437.00 | 391.01 | 414.79 | 1,149,520 | -40.05 | -9.23% |
| 6 Months | 369.21 | 448.40 | 341.90 | 401.28 | 1,328,880 | 24.74 | 6.70% |
| 1 Year | 334.56 | 448.40 | 316.43 | 376.14 | 1,236,576 | 59.39 | 17.75% |
| 3 Years | 217.74 | 448.40 | 176.36 | 281.18 | 1,509,334 | 176.21 | 80.93% |
| 5 Years | 172.40 | 448.40 | 164.07 | 258.36 | 1,543,292 | 221.55 | 128.51% |
Vertex Pharmaceuticals Description
| Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes. |
